Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Nature Cardiovascular Research
|
March 28, 2025
Inflammatory CD248<sup>+</sup> activated fibroblasts are a potential therapeutic target in ischemic heart disease
Joel G Rurik
DNA and Cell Biology
|
April 21, 2022
Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System <i>In Vivo</i> to Treat Heart Disease
Joel G Rurik, Jonathan A Epstein
Circulation Research
|
May 27, 2021
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G Rurik, Haig Aghajanian, Jonathan A Epstein
Nature Metabolism
|
March 1, 2022
CAR-based therapies: opportunities for immuno-medicine beyond cancer
Haig Aghajanian, Joel G Rurik, Jonathan A Epstein
Immunity
|
April 2, 2026
Memory T cell aging and rejuvenation
Sarah Adamo, Joel G Rurik, Claire E Gustafson, et al.
The Journal of Biological Chemistry
|
October 5, 2017
Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of G<sub>q/11</sub> signaling and vascular contraction
Stanley M Kanai, Alethia J Edwards, Joel G Rurik, et al.
Journal of Developmental Biology
|
January 16, 2016
Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation
Robert M Kao, Joel G Rurik, Gist H Farr, et al.
Iscience
|
March 9, 2026
From byproduct to biotherapeutic: Comparative study of buffy coats and leukoreduction system chambers for NK cell-based immunotherapies
Maximiliane Tietze, Maria Schuldt, Martina Wohsmann, et al.
Molecular Cell
|
September 15, 2022
Tissue-specific Grb10/Ddc insulator drives allelic architecture for cardiac development
Aimee M Juan, Yee Hoon Foong, Joanne L Thorvaldsen, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis
Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Nature Cardiovascular Research
|
March 28, 2025
Inflammatory CD248<sup>+</sup> activated fibroblasts are a potential therapeutic target in ischemic heart disease
Joel G Rurik
DNA and Cell Biology
|
April 21, 2022
Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System <i>In Vivo</i> to Treat Heart Disease
Joel G Rurik, Jonathan A Epstein
Circulation Research
|
May 27, 2021
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G Rurik, Haig Aghajanian, Jonathan A Epstein
Nature Metabolism
|
March 1, 2022
CAR-based therapies: opportunities for immuno-medicine beyond cancer
Haig Aghajanian, Joel G Rurik, Jonathan A Epstein
Immunity
|
April 2, 2026
Memory T cell aging and rejuvenation
Sarah Adamo, Joel G Rurik, Claire E Gustafson, et al.
The Journal of Biological Chemistry
|
October 5, 2017
Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of G<sub>q/11</sub> signaling and vascular contraction
Stanley M Kanai, Alethia J Edwards, Joel G Rurik, et al.
Journal of Developmental Biology
|
January 16, 2016
Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation
Robert M Kao, Joel G Rurik, Gist H Farr, et al.
Iscience
|
March 9, 2026
From byproduct to biotherapeutic: Comparative study of buffy coats and leukoreduction system chambers for NK cell-based immunotherapies
Maximiliane Tietze, Maria Schuldt, Martina Wohsmann, et al.
Molecular Cell
|
September 15, 2022
Tissue-specific Grb10/Ddc insulator drives allelic architecture for cardiac development
Aimee M Juan, Yee Hoon Foong, Joanne L Thorvaldsen, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis
Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin, et al.
Page
of 2